CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 74 filers reported holding CYTOSORBENTS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $6,810 | -94.7% | 1,897 | -95.3% | 0.00% | – |
Q1 2022 | $128,000 | -23.8% | 40,176 | -0.0% | 0.00% | – |
Q4 2021 | $168,000 | -49.4% | 40,192 | -1.6% | 0.00% | – |
Q3 2021 | $332,000 | +8.9% | 40,852 | +1.1% | 0.00% | – |
Q2 2021 | $305,000 | -17.3% | 40,427 | -5.0% | 0.00% | -100.0% |
Q1 2021 | $369,000 | +3.1% | 42,558 | -5.3% | 0.00% | – |
Q4 2020 | $358,000 | +11.9% | 44,923 | +11.8% | 0.00% | -100.0% |
Q3 2020 | $320,000 | -26.9% | 40,171 | -9.1% | 0.00% | 0.0% |
Q2 2020 | $438,000 | +46.5% | 44,211 | +14.1% | 0.00% | 0.0% |
Q1 2020 | $299,000 | +100.7% | 38,734 | 0.0% | 0.00% | – |
Q4 2019 | $149,000 | -23.2% | 38,734 | +0.5% | 0.00% | – |
Q3 2019 | $194,000 | -24.5% | 38,527 | -0.8% | 0.00% | – |
Q2 2019 | $257,000 | -20.2% | 38,827 | -8.8% | 0.00% | -100.0% |
Q1 2019 | $322,000 | +4.5% | 42,589 | +11.7% | 0.00% | 0.0% |
Q4 2018 | $308,000 | -3.1% | 38,135 | +54.8% | 0.00% | 0.0% |
Q3 2018 | $318,000 | +7.8% | 24,630 | -4.8% | 0.00% | 0.0% |
Q2 2018 | $295,000 | – | 25,881 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |